Huntington’s disease, an inherited disorder, results in the death of brain cells. Symptoms typically start between 30 and 50 years of age, but it can begin at any age. The disease may develop earlier in life in each successive generation. About 8% of the cases start...
Huntington Disease
Category
Stanford Researchers Study Reveals Need for Better Understanding of Clinical Trial Risks
Stanford University researchers study concludes that clinical trials can offer patients with Huntington’s disease (HD) hope when there are no treatments available despite unknowns whether the therapy will work or is safe. The study results show that although the HD...
Roche & Ionis Pharmaceuticals Study Reduces Levels of Protein Linked to Huntington Disease
An international research team has conducted a clinical trial sponsored by Roche and Ionis Pharmaceuticals, that has demonstrated an experimental drug that can safely lower levels of the mutant protein associated with Huntington disease. The results were recently...